Carregant...
Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
CD133 is currently believed to be one of the best colorectal cancer stem cell markers. This study aimed to evaluate prognostic significance of CD133 expression in colorectal cancer patients. A total of 303 patients with stage I to III colorectal cancer who underwent curative surgical resection from...
Guardat en:
| Publicat a: | Medicine (Baltimore) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708874/ https://ncbi.nlm.nih.gov/pubmed/31393377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016709 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|